| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Neutral amino acid transport by membrane vesicles of Streptococcus cremoris is subject to regulation by internal pH.
|
J Bacteriol
|
1987
|
2.44
|
|
2
|
Elimination of uninformative variables for multivariate calibration.
|
Anal Chem
|
1996
|
2.30
|
|
3
|
Transport of branched-chain amino acids in membrane vesicles of Streptococcus cremoris.
|
J Bacteriol
|
1987
|
1.72
|
|
4
|
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.
|
Br J Cancer
|
2009
|
1.53
|
|
5
|
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
|
Clin Sci (Lond)
|
2003
|
1.43
|
|
6
|
Large-amplitude spin dynamics driven by a THz pulse in resonance with an electromagnon.
|
Science
|
2014
|
1.41
|
|
7
|
Residual infrarenal aortic neck following endovascular and open aneurysm repair.
|
Eur J Vasc Endovasc Surg
|
2012
|
1.38
|
|
8
|
The clinical trail of TRAIL.
|
Eur J Cancer
|
2006
|
1.35
|
|
9
|
Nanoscale spin reversal by non-local angular momentum transfer following ultrafast laser excitation in ferrimagnetic GdFeCo.
|
Nat Mater
|
2013
|
1.31
|
|
10
|
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.
|
Br J Cancer
|
2001
|
1.28
|
|
11
|
Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.
|
Cell Death Differ
|
2013
|
1.27
|
|
12
|
MEIS and PBX homeobox proteins in ovarian cancer.
|
Eur J Cancer
|
2007
|
1.19
|
|
13
|
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
|
Cancer Res
|
1991
|
1.16
|
|
14
|
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic.
|
Crit Rev Oncol Hematol
|
2006
|
1.16
|
|
15
|
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
|
Br J Cancer
|
2008
|
1.15
|
|
16
|
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
|
Ann Rheum Dis
|
2004
|
1.13
|
|
17
|
TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.
|
Drug Resist Updat
|
2009
|
1.11
|
|
18
|
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
|
Gynecol Oncol
|
2005
|
1.08
|
|
19
|
Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature.
|
Crit Rev Oncol Hematol
|
2003
|
1.08
|
|
20
|
Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells?
|
Crit Rev Oncol Hematol
|
2012
|
1.08
|
|
21
|
Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
|
Proc Natl Acad Sci U S A
|
1992
|
1.08
|
|
22
|
Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.
|
Cell Death Dis
|
2011
|
1.04
|
|
23
|
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies.
|
Br J Cancer
|
2006
|
1.01
|
|
24
|
Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion.
|
J Chromatogr A
|
2003
|
0.99
|
|
25
|
Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals.
|
Metabolism
|
1999
|
0.96
|
|
26
|
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
|
J Clin Oncol
|
1998
|
0.96
|
|
27
|
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy.
|
Int J Gynecol Cancer
|
2006
|
0.95
|
|
28
|
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer.
|
Br J Cancer
|
2010
|
0.95
|
|
29
|
Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways.
|
Mol Psychiatry
|
2009
|
0.95
|
|
30
|
Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
|
Int J Cancer
|
2001
|
0.95
|
|
31
|
Targeting TRAIL death receptors.
|
Curr Opin Pharmacol
|
2008
|
0.92
|
|
32
|
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.
|
Br J Cancer
|
2011
|
0.92
|
|
33
|
Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer.
|
Curr Cancer Drug Targets
|
2012
|
0.91
|
|
34
|
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
|
Br J Cancer
|
2003
|
0.91
|
|
35
|
Mathematical modelling of insect neuropeptide potencies. Are quantitatively predictive models possible?
|
Insect Biochem Mol Biol
|
2000
|
0.90
|
|
36
|
Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.
|
Br J Cancer
|
2013
|
0.90
|
|
37
|
Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1.
|
Br J Cancer
|
2002
|
0.88
|
|
38
|
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
|
Br J Cancer
|
1999
|
0.86
|
|
39
|
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates.
|
Scand J Gastroenterol
|
2003
|
0.86
|
|
40
|
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.
|
J Clin Pathol
|
2003
|
0.86
|
|
41
|
Modulation of death receptor pathways in oncology.
|
Drugs Today (Barc)
|
2003
|
0.86
|
|
42
|
A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer.
|
Oncogene
|
2011
|
0.85
|
|
43
|
Sequence specificity of illegitimate plasmid recombination in Bacillus subtilis: possible recognition sites for DNA topoisomerase I.
|
Nucleic Acids Res
|
1998
|
0.84
|
|
44
|
Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas.
|
Cell Oncol
|
2007
|
0.84
|
|
45
|
Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
|
Cell Death Differ
|
2003
|
0.84
|
|
46
|
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.
|
Ann Oncol
|
2009
|
0.84
|
|
47
|
Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.
|
Br J Cancer
|
2007
|
0.83
|
|
48
|
Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
|
Cancer Res
|
1994
|
0.82
|
|
49
|
Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.
|
Br J Cancer
|
2008
|
0.82
|
|
50
|
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.
|
Br J Cancer
|
2005
|
0.82
|
|
51
|
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.
|
Br J Pharmacol
|
2012
|
0.81
|
|
52
|
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53.
|
J Immunother
|
1999
|
0.81
|
|
53
|
Regulation of TRAIL receptor expression by β-catenin in colorectal tumours.
|
Carcinogenesis
|
2013
|
0.80
|
|
54
|
Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon.
|
Br J Cancer
|
2004
|
0.80
|
|
55
|
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.
|
Gynecol Oncol
|
2004
|
0.79
|
|
56
|
Effects of dietary coconut oil, butter and safflower oil on plasma lipids, lipoproteins and lathosterol levels.
|
Eur J Clin Nutr
|
1998
|
0.79
|
|
57
|
Sequential projection pursuit using genetic algorithms for data mining of analytical data.
|
Anal Chem
|
2000
|
0.79
|
|
58
|
Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay.
|
Int J Cancer
|
1986
|
0.78
|
|
59
|
Effect of dietary tocopherols and tocotrienols on the antioxidant status and lipid stability of chicken.
|
Meat Sci
|
2004
|
0.78
|
|
60
|
Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.
|
Expert Rev Mol Med
|
2013
|
0.77
|
|
61
|
Topoisomerases, new targets in cancer chemotherapy.
|
Med Oncol Tumor Pharmacother
|
1990
|
0.77
|
|
62
|
Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
|
Cancer Res
|
1986
|
0.77
|
|
63
|
Investigation of 100 consecutive negative cone biopsies.
|
Br J Obstet Gynaecol
|
1997
|
0.76
|
|
64
|
Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.
|
J Neural Transm (Vienna)
|
2002
|
0.75
|
|
65
|
The potential role of thrombopoietin in idiopathic thrombocytopenic purpura.
|
Blood Rev
|
2002
|
0.75
|
|
66
|
Don't blaze the trailblazer TRAIL too early.
|
Lancet
|
2000
|
0.75
|
|
67
|
[Adjustments in the waiting times].
|
Tijdschr Diergeneeskd
|
2008
|
0.75
|
|
68
|
Feature based fuzzy matching of 2D gel electrophoresis images.
|
J Chem Inf Comput Sci
|
2002
|
0.75
|
|
69
|
An evaluation of direct orthogonal signal correction and other preprocessing methods for the classification of clinical study lots of a dermatological cream.
|
J Pharm Biomed Anal
|
2002
|
0.75
|
|
70
|
Addition of granulocyte colony-stimulating factor to chemotherapy in patients with AIDS-related lymphoma: effects on neutrophil Fc gamma receptor expression and soluble Fc gammaRIII plasma levels.
|
Br J Haematol
|
1997
|
0.75
|
|
71
|
[Metacognition in psychotic disorders: from concepts to intervention].
|
Tijdschr Psychiatr
|
2016
|
0.75
|
|
72
|
[Arson usually is not pyromania].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
|
73
|
Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
|
Anticancer Res
|
1997
|
0.75
|
|
74
|
[What is ergotherapy?].
|
Tijdschr Ziekenverpl
|
1983
|
0.75
|
|
75
|
Matching 2D gel electrophoresis images.
|
J Chem Inf Comput Sci
|
2003
|
0.75
|